Webcast
Vaccine Production: Potential Engineering Approaches to a Pandemic was held April 10 and 11, 2006. The following archived sessions of the conference are available for viewing:
To download MP3 files, right click and select "save target as" to your desktop or other folder.
April 10, 2006
Session 1
- Opening Remarks
- A National Perspective on Pandemic Influenza Preparedness
Bruce Gellin, Department of Health and Human Services, - Pandemic Influenza: A Global Perspective
Klaus Stöhr, WHO Influenza Team - Scientific Methods Underpinning Policy Formulation
for an Influenza Pandemic,
Roy Anderson, FRS, Imperial College, London
Windows Media Player: Session 1
Session 2
- Accelerated Introduction of Pharmaceuticals: The Baseline
Patrick Scannon, Xoma, Ltd.
Windows Media Player: Session 2
Session 3
- Egg-based Influenza Vaccine Production - 30 Years of Commercial Experience and our Future Expectations for Cell Culture
James T. Matthews, sanofi pasteur, US - Cell-culture based Vaccine Production: Technological Options
Rino Rappuoli, Chiron Vaccines Research - Cell-culture based Vaccine Production: Engineering Bottlenecks
Etienne Malhaise, GSK Biologicals - Regulation of Vaccines: Challenges and Opportunities
Norman W. Baylor, Food and Drug Administration
Windows Media Player: Session 3
Session 4
- Panel Discussion
Gary Taubes, Moderator
Windows Media Player: Session 4
April 11, 2006
Session 5
- Opening Remarks
- Surge-capable Peptide Therapeutics and Vaccines
Michael Callahan, DARPA - Alternative Methods of Vaccine Production
Alan Shaw, VaxInnate - A High-Volume, Cost-Effective Microparticle-Based Vaccine Production Process
William L. Warren, VaxDesign Corporation - A Microbial Expression System as a Possible Route to Antigen Production for Use as Vaccines
Lada Rasochova, Dowpharma - Vaccines
Windows Media Player: Session 5
Session 6
- Facility Design & Operational Considerations for the Implementation of Single-Use Disposables in Pandemic Influenza Vaccine Manufacturing
Kim Nelson, CRB Consulting Engineers - Downstream Issues: Vaccine Formulation and Sterile Filling Issues
Shawn Knopp, Michael J. Akers
Baxter BioPharma Solutions
Windows Media Player: Session 6
Real Player: Session 6Session 7
- Paving the Way to Process Understanding: Improving Manufacturing Performance, and Developing Quality Excellence by using Process
Analytical Technology (PAT) in Vaccine Production
Ingrid Maes, Siemens AG, Competence Center Pharmaceutics - Adapting Industry Practice for Rapid, Large Scale Manufacture of Pharmaceutical Proteins
David Estell, Genencor International - Development of a Low Cost Fermentation and Recovery Process for a Commodity Polymer: Nodax™ Polyhydroxyalkanoate
Phillip R. Green, Procter & Gamble Chemical - Accelerated Introduction of Materials in the Aerospace Industry
S. Eric Cregger, The Boeing Company
Windows Media Player: Session 7
Real Player: Session 7Session 8
- Panel Discussion: Next Steps
Gary Taubes, Moderator
Windows Media Player: Session 8
To view the webcast
You must have either Windows Media Player or RealPlayer installed to view the webcast.
To download the latest version of Windows Media Player from the Microsoft Web site:
http://www.microsoft.com/windows/windowsmedia/download/default.asp
To download the latest version of RealPlayer
Media Player from the Microsoft Web site:
http://www.real.com/index.html